• Platanoside Inhibits Ferroptosis in ALI via Keap1-Nrf2-GPX4

  2026-06-08

  This study demonstrates that platanoside prevents ferroptosis-driven acute lung injury by promoting autophagy-dependent Keap1 degradation, thereby activating the Nrf2/GPX4 antioxidant axis. The findings reveal a novel mechanism for mitigating oxidative and inflammatory damage in lung tissue, supporting new directions for redox-targeted therapies.

• Angiotensin 1/2 (5-7): Reliable Solutions for Cell Assays

  2026-06-08

  This article explores laboratory challenges in cell viability, proliferation, and cytotoxicity assays, and demonstrates how Angiotensin 1/2 (5-7) (SKU A1049) provides reproducible, data-backed solutions. Drawing on peer-reviewed evidence and scenario-driven analysis, it guides biomedical researchers on optimizing renin-angiotensin system research workflows using high-purity H2N-Ile-His-Pro-OH peptide reagents.

• n-Dodecyl-β-D-maltoside: Optimized Workflows for Membrane Pr

  2026-06-07

  n-Dodecyl-β-D-maltoside (DDM) is the membrane protein purification reagent of choice for challenging targets like WecA, enabling gentle solubilization and stabilization that preserves native function. Here, we translate recent advances into actionable protocols, troubleshooting tips, and practical guidance for maximizing yield and assay integrity.

• Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-06-06

  This study elucidates how Polo-like kinase 1 (Plk1) modulates the activity of p31comet during the disassembly of mitotic checkpoint complexes (MCC), a critical process for accurate chromosome segregation. By mapping Plk1-dependent phosphorylation of p31comet and detailing its functional consequences, the research advances our understanding of mitotic checkpoint regulation with implications for cell cycle and cancer biology.

• Tioconazole in Antifungal Research: Advanced Protocols and I

  2026-06-05

  Tioconazole stands out as a high-purity antifungal medication, enabling robust experimental workflows for drug development and fungal infection models. This guide translates recent mechanistic discoveries into actionable protocols, troubleshooting strategies, and advanced use-cases for biomedical researchers.

• APEX2's Role in TERT Expression Regulation in Human Stem Cel

  2026-06-05

  This study demonstrates that APEX2, but not its paralog APEX1, is essential for efficient TERT gene expression in human embryonic stem cells. By revealing a link between DNA repair enzymes, repetitive DNA elements, and telomerase regulation, the work advances our understanding of telomere maintenance and potential cancer therapeutics.

• Angiotensin II: Mechanism-Guided Strategies for Vascular Dis

  2026-06-04

  This article provides translational researchers with a mechanistic roadmap for leveraging Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in advanced vascular disease models. Bridging mitochondrial NAD+ biology, extracellular matrix turnover, and the pathogenesis of aneurysm, we articulate how APExBIO’s Angiotensin II enables high-fidelity mechanistic studies. Protocol guidance, differentiation from conventional approaches, and future outlooks are delivered for credible, actionable research design.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Workflow Gui

  2026-06-04

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit delivers customizable, high-yield fluorescent RNA probes for sensitive applications like in situ hybridization and Northern blotting. Its tunable Cy5-UTP incorporation and robust protocol empower researchers to optimize probe performance for demanding workflows.

• Rifampin for Transcription Inhibition: Advanced Workflows &

  2026-06-03

  Rifampin stands out as a benchmark rifamycin antibiotic for probing bacterial transcription, engineering synthetic biology circuits, and modeling resistance. This guide translates the latest research and proven workflows into actionable, high-fidelity protocols for consistent results in transcriptional regulation studies.

• Cyclic Pifithrin-α hydrobromide: Reliable p53 Inhibition in

  2026-06-03

  This article addresses critical workflow challenges in cell viability and apoptosis assays, demonstrating how Cyclic Pifithrin-α hydrobromide (SKU A4477) enables reproducible p53 pathway inhibition. Through scenario-driven Q&A, it provides actionable guidance for biomedical researchers seeking robust, data-backed solutions in cancer and neuroinflammation models.

• Senescence Genes as Biomarkers in Abdominal Aortic Aneurysm

  2026-06-02

  This study applies integrative transcriptomic and machine learning strategies to identify senescence-related genes as noninvasive biomarkers for abdominal aortic aneurysm (AAA). The validation of ETS1 and ITPR3 as diagnostic candidates offers new avenues for early AAA detection and potential therapeutic targeting.

• ETS1 Modulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-06-02

  The referenced study identifies ETS1 as a key regulator of mitophagy in bronchopulmonary dysplasia (BPD), acting through the SENP2/HSPA8/FUNDC1 axis to inhibit mitochondrial damage-induced autophagy. These findings offer new mechanistic insight into lung injury and suggest targeted strategies for autophagy pathway modulation in neonatal lung disease.

• SQOR Drives Ferroptosis Resistance in Hypoxic Pancreatic Can

  2026-06-01

  Lin et al. provide a comprehensive multi-omics and deep learning analysis revealing that upregulation of SQOR promotes ferroptosis resistance in hypoxic pancreatic ductal adenocarcinoma (PDAC). Their findings establish SQOR as a pivotal regulator of tumor cell survival under hypoxia and highlight its potential as a therapeutic target.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Advancing Ma

  2026-06-01

  Explore the HyperScribe T7 High Yield Cy5 RNA Labeling Kit's pivotal role in high-sensitivity RNA probe synthesis for efferocytosis and inflammation research. Gain unique insight into how Cy5 RNA labeling empowers cutting-edge studies in macrophage-mediated clearance, bridging innovative methodology with translational impact.

• Tofacitinib (CP-690550): Rewiring Macrophage Immunometabolis

  2026-05-31

  Explore how Tofacitinib (CP-690550) enables translational researchers to target both inflammatory and metabolic dysfunction in rheumatoid arthritis macrophages. This thought-leadership piece uniquely integrates mechanistic insights, actionable protocols, and strategic guidance, advancing beyond standard product literature to empower the next wave of immune modulation research.

15975 records 5/1065 page Previous Next 12345 下5页 Last page